Literature DB >> 33085800

Role of clinical pharmacists in telemonitoring for patients with Coronavirus Disease 2019 (COVID-19).

Bhitta Surapat1, Somnuek Sungkanuparph2, Suppachok Kirdlarp2, Nantaporn Lekpittaya1, Krittaya Chunnguleum3.   

Abstract

WHAT IS KNOWN AND
OBJECTIVE: Clinical pharmacists actively participate in patient care via patients' medication use. Yet the setting of Coronavirus Disease 2019 (COVID-19) limits patient contact with healthcare personnel. We aimed to review the services provided and drug-related problems detected using telemonitoring methods to guide clinical pharmacists in providing service in treating COVID-19 patients. COMMENT: At a tertiary care hospital in Thailand, clinical pharmacists provided pharmaceutical care services for COVID-19 patients via telemonitoring using the hospital's computerized physician order entry system. The pharmacists were able to provide therapeutic drug monitoring services, especially for anticoagulants. Many patients were considered special populations, with individualized requirements for drug dosing. Some adverse drug reactions were observed. Drug-related problems were mostly related to medication use in critically ill patients. WHAT IS NEW AND
CONCLUSION: Telemonitoring is a viable method for clinical pharmacists to provide pharmaceutical care and meet the challenges posed by treating patients with COVID-19.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  adverse effect; clinical pharmacy; drug interactions; pharmaceutical care; pharmacist consultation; therapeutic drug monitoring

Year:  2020        PMID: 33085800     DOI: 10.1111/jcpt.13293

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  7 in total

Review 1.  Intelligent Telehealth in Pharmacovigilance: A Future Perspective.

Authors:  Heba Edrees; Wenyu Song; Ania Syrowatka; Aurélien Simona; Mary G Amato; David W Bates
Journal:  Drug Saf       Date:  2022-05-17       Impact factor: 5.228

Review 2.  A comprehensive review on global contributions and recognition of pharmacy professionals amidst COVID-19 pandemic: moving from present to future.

Authors:  Saad Ahmed Sami; Kay Kay Shain Marma; Agnila Chakraborty; Tandra Singha; Ahmed Rakib; Md Giash Uddin; Mohammed Kamrul Hossain; S M Naim Uddin
Journal:  Futur J Pharm Sci       Date:  2021-06-11

Review 3.  Expanded roles of community pharmacists in COVID-19: A scoping literature review.

Authors:  Tanapong Pantasri
Journal:  J Am Pharm Assoc (2003)       Date:  2021-12-24

4.  Survey of the patients' perspectives and preferences in adopting telepharmacy versus in-person visits to the pharmacy: a feasibility study during the COVID-19 pandemic.

Authors:  Khadijeh Moulaei; Mostafa Shanbehzadeh; Kambiz Bahaadinbeigy; Hadi Kazemi-Arpanahi
Journal:  BMC Med Inform Decis Mak       Date:  2022-04-13       Impact factor: 2.796

Review 5.  The Pharmacist's Role in Managing COVID-19 in Chronic Kidney Disease Patients: A Review of Existing Strategies and Future Implications.

Authors:  Mohammed Salim Karattuthodi; Shabeer Ali Thorakkattil; Suhaj Abdulsalim; Sathvik Belagodu Sridhar; Sainul Abideen Parakkal; Savera Arain; Hafees Madathil; Ajmal Karumbaru Kuzhiyil; Mamdouh Mohammed Ahmed Ageeli; Mazhuvanchery Kesavan Unnikrishnan
Journal:  Pharmacy (Basel)       Date:  2022-08-05

6.  Adverse drug reactions and drug interactions in the treatment of hospitalized patients with coronavirus disease 2019 (COVID-19).

Authors:  Tatiana A Marins; Alexandre R Marra; Michael B Edmond; Ligia Regina Prystaj Colombo; Sthephanie Favalli Vieira; Fernanda de Oliveira Xavier; Alessandra Gomes Chauvin; João Renato Rebello Pinho; Silvana M de Almeida; Marcelino Souza Durão Junior
Journal:  Antimicrob Steward Healthc Epidemiol       Date:  2021-10-28

Review 7.  COVID the Catalyst for Evolving Professional Role Identity? A Scoping Review of Global Pharmacists' Roles and Services as a Response to the COVID-19 Pandemic.

Authors:  Kaitlyn E Watson; Theresa J Schindel; Marina E Barsoum; Janice Y Kung
Journal:  Pharmacy (Basel)       Date:  2021-05-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.